Exact Sciences (NASDAQ:EXAS) Now Covered by Analysts at Royal Bank of Canada
Analysts at Royal Bank of Canada assumed coverage on shares of Exact Sciences (NASDAQ:EXAS – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The firm set a “sector perform” rating and a $52.00 price target on the medical research company’s stock. Royal Bank of Canada’s target price would suggest a […]
